Loading...
•
Sep 30, 2023
Definitive Healthcare Q3 2023 Earnings Report
Definitive Healthcare's financial performance for Q3 2023 increased, with revenue growing and adjusted EBITDA profitability improving.
Key Takeaways
Definitive Healthcare reported a 14% year-over-year increase in revenue, reaching $65.3 million for Q3 2023. The company's adjusted EBITDA was $21.7 million, representing 33% of revenue, compared to $16.4 million in Q3 2022.
Revenue increased by 14% year-over-year to $65.3 million.
Net loss was ($248.7) million, or 381% of revenue.
Adjusted Net Income increased to $14.6 million, compared to $8.8 million in Q3 2022.
Adjusted EBITDA was $21.7 million, or 33% of revenue, compared to $16.4 million, or 29% of revenue in Q3 2022.
Forward Guidance
The Company is issuing the following financial guidance for Fourth Quarter 2023:
Positive Outlook
- Revenue is expected to be in the range of $65.5 – $66.5 million, an 8-10% increase year over year.
- Adjusted Operating Income is expected to be in the range of $17.5 – $18.5 million.
- Adjusted EBITDA is expected to be in the range of $19 – $20 million.
- Adjusted Net Income is expected to be $11.5 – $12.5 million.
- Adjusted Net Income Per Diluted Share is expected to be $0.06 – $0.08 per share on approximately 155.6 million weighted-average shares outstanding.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...